Advertisement

Hemostatic Abnormalities in Tumor-Bearing Animals

  • Maria Benedetta Donati
Part of the Developments in Oncology book series (DION, volume 22)

Abstract

Although the first description of vascular thrombosis in cancer patients is more than one century old (1), several unresolved questions still remain on the involvement of the hemostatic system in malignancy. First, clinical studies have repeatedly demonstrated that malignant disease is associated with a high incidence of hemostatic disorders, ranging from isolated abnormalities of laboratory tests to vascular thrombosis, hemorrhage or overt disseminated intravascular coagulation (DIC). On the other hand, using different techniques, several investigators have shown the presence of fibrin deposits in and around tumors as a sign of the activation of clotting in malignancy (2–4).

Keywords

Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Fibrinolytic Activity Microangiopathic Hemolytic Anemia Hemostatic System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Trousseau A. Clinique Medicale de l’Hotel-Dieu de Paris J.B. Bailliere et Fils, Paris, 5th Edition, 3: 94 1865.Google Scholar
  2. 2.
    Donati MB, Davidson JF and Garrattini S. Malignancy and the Hemostatic System. Raven Press, New York, 1981.Google Scholar
  3. 3.
    Donati MB and Poggi A. Br. J. Haematol. 44: 173–182, 1980.PubMedCrossRefGoogle Scholar
  4. 4.
    Donati MB, Poggi A and Semeraro N. In: Recent Advances in Blood Coagulation (Ed. Poller L), Churchill Livingstone, Edinburgh, pp. 227–259, 1981.Google Scholar
  5. 5.
    Poggi A, Donati MB and Garrattini S. In: Malignancy and the Hemostatic System (Eds. Donati MB, Davidson JF and Garattini S), Raven Press, New York, pp. 89–101, 1981.Google Scholar
  6. 6.
    Poste G and Fidler LJ. Nature (London) 283: 139–146, 1980.CrossRefGoogle Scholar
  7. 7.
    Hilgard P, Hohage R, Schmitt W and Kohle W. Br. J. Haematol. 24: 245–254, 1973.PubMedCrossRefGoogle Scholar
  8. 8.
    Hilgard P and Gordon-Smith EC. Br. J. Haematol. 26: 651 - 659, 1974.PubMedCrossRefGoogle Scholar
  9. 9.
    Poggi A, Polentarutti N, Donati MB, de Gaetano G and Garattini S. Cancer Res. 37: 272–277, 1977.PubMedGoogle Scholar
  10. 10.
    Mussoni L, Poggi A, Donati MB and de Gaetano G. Haemostasis 6: 260–265, 1977.PubMedGoogle Scholar
  11. 11.
    Poggi A, Mussoni L, Kornblihtt L, Ballabio E, de Gaetano G and Donati MB. Lancet 1: 163 – 164, 1978.PubMedCrossRefGoogle Scholar
  12. 12.
    Donati MB, Rotilio D, Delaini F, Giavazzi R, Mantovani A and Poggi A. In: Interaction of Platelets and Tumor Cells (Ed. Jamieson GA), Alan R. Liss, New York, pp. 159–176, 1982.Google Scholar
  13. 13.
    Delaini F, Colucci M, De Bellis Vitti G, Locati D, Poggi A, Semeraro N and Donati MB. Thromb. Res. 24: 263–266, 1981.PubMedCrossRefGoogle Scholar
  14. 14.
    Valori VM, Buczko W, Delaini F, Lampugnani MG, Di Palo L, Herberman RB and Donati MB. Thromb. Haemostasis 50: 214, 1983.Google Scholar
  15. 15.
    Giraldi T, Sava G, Mitri E and Cherubino R. Eur. J. Cancer Clin. Oncol, (in press), 1983.Google Scholar
  16. 16.
    Donati MB. In: Blood Coagulation and Haemostasis. A Practical Guide. (Ed. Thomson JM), Churchill Livingstone, Edinburgh, pp. 158–199, 1980.Google Scholar
  17. 17.
    Omielweska J, Poggi A, Mussoni L, Donati MB and Garattini S. Eur. J. Cancer 16: 1399–1407, 1980.CrossRefGoogle Scholar
  18. 18.
    Raczka E, Quintana A, Poggi A and Donati MB. Eur. J. Cancer Clin. Oncol, (in press), 1983.Google Scholar
  19. 19.
    Curatolo L, Colucci M, Cambini AL, Poggi A, Morasca L, Donati MB and Semeraro N. Br. J. Cancer 40: 228–233, 1979.PubMedCrossRefGoogle Scholar
  20. 20.
    Latallo ZS, Kowalski-Loth B, Chmielewska J, Teisseyre E, Raczka E and Kopec M. In: Progress in Chemical Fibrinolysis and Thrombolysis (Eds. Davidson JF, Cepelak V, Samama MM and Desnoyers PC), Churchill Livingstone, Edinburgh, Vol. 4, pp. 411–415, 1979.Google Scholar
  21. 21.
    Yuhas JM and Pazmino NH. Cancer Res. 34: 2005–2010, 1974.PubMedGoogle Scholar
  22. 22.
    Giavazzi R, Alessandri G, Spreafico R, Garattini S and Mantovani A. Br. J. Cancer 42: 462–472, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Delaini F, Giavazzi R, De Bellis Vitti G, Alessandri G, Mantovani A and Donati MB. Br. J. Cancer 43: 100–104, 1981.PubMedCrossRefGoogle Scholar
  24. 24.
    Colucci M, Giavazzi R, Alessandri G, Semeraro N, Mantovani A and Donati MB. Blood 57: 733–735, 1981.PubMedGoogle Scholar
  25. 25.
    Astedt B. In: Malignancy and the Hemostatic System (Eds. Donati MB, Davidson JF and Garattini S), Raven Press, New York, pp. 83–88, 1981.Google Scholar
  26. 26.
    Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, Mantovani A and Donati MB. Blood (in press), 1983.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Maria Benedetta Donati

There are no affiliations available

Personalised recommendations